Eisai Collaboration

The University of Dundee and Eisai Co., Ltd. are continuing a partnership established in 2019, combining Dundee’s expertise in targeted protein degradation (TPD) with Eisai’s oncology research and clinical development experience. TPD is transforming drug discovery and provides hope for treating diseases previously considered undruggable. Over the past years, the collaboration has achieved significant progress in targeting a cancer-associated protein with small molecule degraders and aims to build on this success.